Aimo procurement knowledge hub · Five priority systems

Five pet-care systems, one evidence discipline

This hub helps overseas brands decide what Aimo can coordinate now, what remains conditional, what evidence should be requested, and which claims should not be assumed. It is designed for procurement, product development and quality review—not for ranking claims.

Why these five, not a generic catalogue?

Recurring care

Ear, wipe, oral and paw routines are replenishment-led rather than one-time novelty products.

System expansion

Each buyer can begin with one SKU and expand into a coordinated liquid, wipe, paste, balm or professional format after evidence gates clear.

Current market signals

APPA’s 2026 Dog Report says 46% of US dog owners own dental-care products and dog-wipe ownership increased 108% year over year.

Evidence before scale

The public commercial counterparty, producing entity, tests, certificates, MOQ and market responsibilities are kept separate.

Market context: APPA 2026 Dog Report release; APPA industry statistics; FEDIAF European statistics. Market growth does not guarantee an OEM inquiry or order.

One role statement across every page

Aimo is the public brand. Guangzhou Aimo Pet Products Co., Ltd. is the commercial and export counterparty for private-label pet-care projects. The producing legal entity, site, process, tests and market responsibility are confirmed for the exact SKU before approval.

For buyers

Use the category pages to prepare a complete brief, then request the evidence items listed for the exact SKU. Do not rely on generic certificates or unrelated product reports.